4-bromo-N-(2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridin-3-yl)benzamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-bromo-N-(2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridin-3-yl)benzamide
• 英文别名: 4-bromo-N-(1,2-dihydro-2-oxo-5-(pyridin-4-yl)pyridin-3-yl)benzamide；4-bromo-N-(2-oxo-5-pyridin-4-yl-1H-pyridin-3-yl)benzamide
• 化学式: C₁₇H₁₂BrN₃O₂
• 分子量: 370.205
• InChiKey: AIMKMUZCGLXPSV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  71.1
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-bromo-N-(2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridin-3-yl)benzamide 、 哌啶 在 哌啶 、 crude compound 、 甲醇 作用下， 以 N-甲基吡咯烷酮 为溶剂， 反应 2.0h， 以to give the title compound as a white solid (13 mg, 43% yield)的产率得到N-(2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridin-3-yl)-4-piperidin-1-ylbenzamide
  参考文献：
  名称：

  Pyridones useful as inhibitors of kinases

  摘要：

  本发明涉及可用作蛋白激酶抑制剂的化合物。本发明还提供了包含该化合物的药学上可接受的组合物以及使用该组合物治疗各种疾病、病况或障碍的方法。本发明还提供了制备该发明化合物的过程以及在这些过程中有用的中间体化合物。

  公开号：

  US08338597B2
• 作为产物：
  描述：

  4-溴苯甲酰氯 、 氨力农 在 吡啶 作用下， 反应 16.0h， 以52%的产率得到4-bromo-N-(2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridin-3-yl)benzamide
  参考文献：
  名称：

  Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition

  摘要：

  Screening a 3-aminopyridin-2-one based fragment library against a 26-kinase panel representative of the human kinome identified 3-amino 5 (1-methyl-1H-pyrazol-4-yl)pyridin-2(1H)-one (2) and 3-amino-5(pyridin-4-yl)pyridin-2(1H)-one (3) as ligand efficient inhibitors of the mitotic kinase Monopolar Spindle 1 (MPS1) and the Aurora kinase family. These kinases are well recognised as attractive targets for therapeutic intervention for treating cancer. Elucidation of the binding mode of these fragments and their analogues has been carried out by X-ray crystallography. Structural studies have identified key interactions with a conserved lysine residue and have highlighted potential regions of MPS1 which could be targeted to improve activity and selectivity. (C) 2018 The Authors. Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmc.2018.04.033

文献信息

• Pyridones useful as inhibitors of kinases
  申请人：Charrier Jean-Damien

  公开号：US20060183911A1

  公开（公告）日：2006-08-17

  The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing the compounds of the invention and intermediate compounds useful in these processes.

  本发明涉及一种作为蛋白激酶抑制剂有用的化合物。本发明还提供了包含所述化合物的药学上可接受的组合物，以及使用这些组合物治疗各种疾病、状况或障碍的方法。本发明还提供了制备本发明化合物和在这些过程中有用的中间化合物的方法。
• PYRIDONES USEFUL AS INHIBITORS OF KINASES
  申请人：Charrier Jean-Damien

  公开号：US20120190699A1

  公开（公告）日：2012-07-26

  The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing the compounds of the invention and intermediate compounds useful in these processes.

  本发明涉及用作蛋白激酶抑制剂的化合物。本发明还提供了包含所述化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病、状况或障碍的方法。本发明还提供了制备本发明化合物和在这些过程中有用的中间化合物的方法。
• WO2006/65946
  申请人：——

  公开号：——

  公开（公告）日：——
• PYRID-2-ONES USEFUL AS INHIBITORS OF TEC FAMILY PROTEIN KINASES FOR THE TREATMENT OF INFLAMMATORY, PROLIFERATIVE AND IMMUNOLOGICALLY-MEDIATED DISEASES.
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：EP1831168A1

  公开（公告）日：2007-09-12
• US8101770B2
  申请人：——

  公开号：US8101770B2

  公开（公告）日：2012-01-24